Earli is on a mission to transform oncology with its Synthetic Biopsy

Retrieved on: 2024-09-08 00:52:00

Tags for this article:

Biotechnology

Cyriac Roeding

Artificial intelligence in healthcare

Cancer research

Synthetic biology

Cancer

Personalized medicine

Breast cancer

Click the tags to see associated articles and topics

Earli is on a mission to transform oncology with its Synthetic Biopsy. View article details on hiswai:

Excerpt

The list includes Andreessen Horowitz, Khosla Ventures, Perceptive Advisors, Casdin Capital, Sands Capital, Menlo Ventures, ZhenFund (China), and Marc ...

Article found on: www.drugdiscoverytrends.com

View Original Article